Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

Bibliographic Details
Title: Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Authors: Blay, Jean-Yves, Pápai, Zsuzsanna, Tolcher, Anthony W, Italiano, Antoine, Cupissol, Didier, López-Pousa, Antonio, Chawla, Sant P, Bompas, Emmanuelle, Babovic, Nada, Penel, Nicolas, Isambert, Nicolas, Staddon, Arthur P, Saâda-Bouzid, Esma, Santoro, Armando, Franke, Fabio A, Cohen, Patrick, Le-Guennec, Solenn, Demetri, George D
Source: In The Lancet Oncology May 2015 16(5):531-540
Database: ScienceDirect
More Details
ISSN:14702045
DOI:10.1016/S1470-2045(15)70102-6
Published in:The Lancet Oncology
Language:English